(XHR) Xenia Hotels & Resorts - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9840171030

Hotels, Resorts, Luxury, Accommodations, Hospitality

Stock: Hotel & Resort REITs
Age 11y

MCap 1,491m
Avg Vol 791K (11.7M USD)

Beta 1.251
Volatility 26.60%

EPS (Earnings per Share)

EPS CAGR: 11.62%
EPS Trend: 1.2%

Last SUE: -0.50
Qual. Beats: 0

Revenue

Rev. CAGR: 4.07%
Rev. Trend: 44.4%

Last SUE: 0.10
Qual. Beats: 0

Dividends

Dividend Yield	4.31%
Yield on Cost 5y	3.99%
Yield CAGR 5y	40.95%
Payout Consistency	76.3%
Payout Ratio	87.5%

Risk via 5d forecast
Volatility	26.6%
Value at Risk 5%th	39.2%
Relative Tail Risk	-10.46%

Reward TTM
Sharpe Ratio	0.12
Alpha	-16.93
CAGR/Max DD	0.10

Character TTM
Hurst Exponent	0.506
Beta	1.251
Beta Downside	1.220

Drawdowns 3y
Max DD	42.47%
Mean DD	12.91%
Median DD	12.04%

Description: XHR Xenia Hotels & Resorts January 16, 2026

Xenia Hotels & Resorts, Inc. (NYSE: XHR) is a self-advised, self-administered REIT that concentrates on luxury and upper-upscale hotels in the United States’ top 25 lodging markets and key leisure destinations. The portfolio comprises 30 properties, totaling 8,868 rooms across 14 states, and is operated under brand licenses from industry leaders such as Marriott, Hyatt, Hilton, and Fairmont.

As of FY 2023, XHR reported funds-from-operations (FFO) of roughly $0.93 per share and an average occupancy of 71% with an ADR of $166, yielding a RevPAR near $118-metrics that remain modestly below the luxury-segment peer average of $124 RevPAR. The company’s leverage stood at a net debt-to-FFO ratio of about 1.3×, indicating a balance between growth-oriented acquisition capacity and financial risk.

Key drivers for XHR’s performance include (1) the ongoing rebound in discretionary travel spending, which the U.S. Travel Association projects to grow at ~3% YoY through 2025; (2) the sensitivity of luxury-segment demand to macro-economic conditions, particularly consumer confidence and high-income employment trends; and (3) the REIT’s pipeline of five development projects slated for completion by 2026, which could add roughly 1,200 rooms and enhance geographic diversification.

For a deeper, data-driven dive into XHR’s valuation metrics, the ValueRay platform offers a transparent, model-based view.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (56.4m TTM) > 0 and > 6% of Revenue (6% = 64.5m TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA 2.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 15.46% (prev 12.36%; Δ 3.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 185.7m > Net Income 56.4m (YES >=105%, WARN >=100%)

Net Debt (1.23b) to EBITDA (234.0m) ratio: 5.28 <= 3.0 (WARN <= 3.5)

Current Ratio 2.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (95.2m) change vs 12m ago -6.55% (target <= -2.0% for YES)

Gross Margin 22.18% (prev 24.49%; Δ -2.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 37.24% (prev 35.48%; Δ 1.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.21 (EBITDA TTM 234.0m / Interest Expense TTM 84.9m) >= 6 (WARN >= 3)

Altman Z'' -0.56

(A) 0.06 = (Total Current Assets 299.3m - Total Current Liabilities 133.2m) / Total Assets 2.87b

(B) -0.23 = Retained Earnings (Balance) -663.6m / Total Assets 2.87b

(D) -0.40 = Book Value of Equity -662.4m / Total Liabilities 1.64b

Total Rating: -0.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 52.76

1. Piotroski 4.50pt

2. FCF Yield 3.32%

3. FCF Margin 8.43%

4. Debt/Equity 1.21

5. Debt/Ebitda 5.28

6. ROIC - WACC (= -2.88)%

7. RoE 4.65%

8. Rev. Trend 44.39%

9. EPS Trend 1.15%

What is the price of XHR shares?

As of January 21, 2026, the stock is trading at USD 14.53 with a total of 493,212 shares traded.
Over the past week, the price has changed by -1.49%, over one month by -1.20%, over three months by +10.48% and over the past year by +1.21%.

Is XHR a buy, sell or hold?

Xenia Hotels & Resorts has received a consensus analysts rating of 3.71. Therefor, it is recommend to hold XHR.

Strong Buy: 3
Buy: 1
Hold: 2
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the XHR price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	16.4	12.9%
Analysts Target Price	16.4	12.9%
ValueRay Target Price	16.1	10.7%

XHR Fundamental Data Overview January 19, 2026

P/E Trailing = 26.1964
P/E Forward = 63.2911
P/S = 1.3869
P/B = 1.1813
Revenue TTM = 1.07b USD
EBIT TTM = 102.5m USD
EBITDA TTM = 234.0m USD
Long Term Debt = 1.42b USD (from longTermDebt, last quarter)
Short Term Debt = 4.43m USD (from shortTermDebt, last fiscal year)
Debt = 1.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.23b USD (from netDebt column, last quarter)
Enterprise Value = 2.73b USD (1.49b + Debt 1.42b - CCE 188.2m)
Interest Coverage Ratio = 1.21 (Ebit TTM 102.5m / Interest Expense TTM 84.9m)
EV/FCF = 30.08x (Enterprise Value 2.73b / FCF TTM 90.6m)
FCF Yield = 3.32% (FCF TTM 90.6m / Enterprise Value 2.73b)
FCF Margin = 8.43% (FCF TTM 90.6m / Revenue TTM 1.07b)
Net Margin = 5.24% (Net Income TTM 56.4m / Revenue TTM 1.07b)
Gross Margin = 22.18% ((Revenue TTM 1.07b - Cost of Revenue TTM 836.4m) / Revenue TTM)
Gross Margin QoQ = 5.65% (prev 29.27%)
Tobins Q-Ratio = 0.95 (Enterprise Value 2.73b / Total Assets 2.87b)
Interest Expense / Debt = 1.53% (Interest Expense 21.8m / Debt 1.42b)
Taxrate = 21.0% (US default 21%)
NOPAT = 81.0m (EBIT 102.5m * (1 - 21.00%))
Current Ratio = 2.25 (Total Current Assets 299.3m / Total Current Liabilities 133.2m)
Debt / Equity = 1.21 (Debt 1.42b / totalStockholderEquity, last quarter 1.18b)
Debt / EBITDA = 5.28 (Net Debt 1.23b / EBITDA 234.0m)
Debt / FCF = 13.63 (Net Debt 1.23b / FCF TTM 90.6m)
Total Stockholder Equity = 1.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.95% (Net Income 56.4m / Total Assets 2.87b)
RoE = 4.65% (Net Income TTM 56.4m / Total Stockholder Equity 1.21b)
RoCE = 3.89% (EBIT 102.5m / Capital Employed (Equity 1.21b + L.T.Debt 1.42b))
RoIC = 3.10% (NOPAT 81.0m / Invested Capital 2.61b)
WACC = 5.98% (E(1.49b)/V(2.91b) * Re(10.53%) + D(1.42b)/V(2.91b) * Rd(1.53%) * (1-Tc(0.21)))
Discount Rate = 10.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.77%
[DCF Debug] Terminal Value 84.86% ; FCFF base≈64.6m ; Y1≈58.1m ; Y5≈49.8m
Fair Price DCF = 2.46 (EV 1.47b - Net Debt 1.23b = Equity 233.0m / Shares 94.8m; r=5.98% [WACC]; 5y FCF grow -12.43% → 2.90% )
EPS Correlation: 1.15 | EPS CAGR: 11.62% | SUE: -0.50 | # QB: 0
Revenue Correlation: 44.39 | Revenue CAGR: 4.07% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.16 | Chg30d=-0.010 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.27 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+0.0% | Growth Revenue=+3.4%

Additional Sources for XHR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle